A landmark international study involving 5,020 patients has challenged the standard treatment approach for uncomplicated heart attacks, revealing that beta blockers provide no meaningful clinical benefit for patients with preserved heart function. The research, conducted between 2010 and 2022 across multiple countries and published in the New England Journal of Medicine, suggests that current modern cardiac care—including blood thinners, statins, and coronary interventions—may have fundamentally altered the therapeutic landscape since beta blockers were established as standard care in the 1980s. Dr. Sanne Jorstad, lead investigator from Amsterdam University Medical Centers, emphasizes that treatment protocols must evolve with medical advancement. The findings raise critical questions about whether millions of patients worldwide are receiving unnecessary medication, warranting a comprehensive reassessment of post-acute myocardial infarction management strategies.
Was this article helpful?
